Zions Bancorporation (NASDAQ:ZION) Beats Q3 2026 EPS Estimates

Zions Bancorporation (ZION) reported Q3 2026 earnings, beating EPS estimates with $1.78 but missing revenue forecasts at $881M. Deposits grew 8.8% annualized, while net interest margin compressed to 3.23%. Shares rose 0.98% after-hours. The bank expanded capital markets and wealth management, acquiring an agency multifamily business.

Nasdaq rose 1.11% while Dow slipped 0.07%, with S&P 500 up 0.66%. VIX fell 1.55 points. Lockheed Martin delivered a C-130J-30 to the U.S. Navy. F.N.B. reported Q3 net income of $152.9M. Haemonetics got FDA approval for PerQseal Elite. Zions Bancorporation Q3 earnings rose 20% YoY. Crown Holdings Q3 EPS up to $2.08.

Zions (ZION) reported Q3 EPS of $1.78, beating estimates by $0.12, but revenue of $881M fell slightly short. Stock is down 8.70% in 3 months but up 21.47% in 12 months. InvestingPro rates its financial health as 'good performance.'

Zions Bancorp (ZION) reported Q3 earnings of $263M, or $1.78 per share, beating estimates of $1.64 per share. Revenue was $1.24B, with net revenue of $893M, also exceeding forecasts.

Zions Bancorp reported 3Q26 net earnings of $262M, up from $221M in 3Q25, with diluted EPS of $1.78. Net interest income was $684M, and the CET1 ratio rose to 11.8%. Loans and deposits grew by 4% year-over-year, while nonperforming assets declined.

Zions Bancorporation reported Q3 GAAP EPS of $1.78, exceeding estimates by $0.12. Revenue was $881M, up 1.0% year-over-year but missing expectations by $10.93M.